Only very few CD4+ effector T cells, representing 1% of tumour-infiltrating immune cells, locate at the tumour invasive margins where they interact with CD11c+MHC-II+ antigen-presenting immune cells and indirectly eliminate tumours. This evidence concerns the gene ITGAX and neoplasm.